Oct 16 (Reuters) – The European Medicines Agency’s committee on Friday recommended approval of Eli Lilly’s weight-loss pill Foundayo, paving the way for a second oral weight-loss drug to win backing in the region after Novo Nordisk’s Wegovy pill.
(Reporting by Sriparna Roy in Bengaluru; Editing by Tasim Zahid)
Comments